Published on 13 Oct 2021 on Benzinga
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday’s regular trading session, extending gains to a second straight day.
What Happened: Ocugen’s shares extended their rally on Tuesday after it was reported that an expert panel of India’s drug regulator has recommended Bharat Biotech's COVID-19 vaccine, Covaxin, for children between the age of two and 18.